Key result
Hospitalized patients with a secondary diagnosis of heart failure had a higher 1-year mortality rate and higher healthcare costs compared to those with a primary heart failure diagnosis.
Why the study?
Information on patients with a secondary heart failure diagnosis compared to those with a primary heart failure diagnosis is scarce.
Does a secondary heart failure diagnosis worsen clinical outcomes and increase healthcare costs compared to a primary heart failure diagnosis in patients presenting to the emergency department?
Observational (n=3,083)
No
Does a secondary heart failure diagnosis worsen clinical outcomes and increase healthcare costs compared to a primary heart failure diagnosis in patients presenting to the emergency department?
Answers are grounded in this paper and cite their sources.
Higher mortality in secondary HF hospitalization signals clinical vigilance; leaves open whether comorbidity-focused strategies improve outcomes.
Background There is scarce information on patients with secondary heart failure diagnosis (sHF). We aimed to compare the characteristics, burden, and outcomes of sHF with those with primary HF diagnosis (pHF). Methods Retrospective, observational study on patients ≥18 years with emergency department (ED) visits during 2018 with pHF and sHF in ED or hospital (ICD-10-CM) diagnostic codes. Baseline characteristics, 30-day and 1-year mortality, readmission and re-ED visit rates, and costs were compared between sHF and pHF. Results Out of the 797 patients discharged home from the ED, 45.5% had sHF, and these presented lower 1-year hospitalization, re-ED visit rates, and costs. In contrast, out of the 2,286 hospitalized patients, 55% had sHF and 45% pHF. Hospitalized sHF patients had significantly ( p < 0.01) greater comorbidity, lower use of recommended HF therapies, longer length of stay (10.8 ± 10.1 vs. 9.7 ± 7.9 days), and higher in-hospital and 1-year mortality (32 vs. 25.8%) with no significant differences in readmission rates and lower 1-year re-ED visit rate. Hospitalized sHF patients had higher total costs (€12,262,422 vs. €9,144,952, p < 0.001), mean cost per patient-year (€9,755 ± 13,395 vs. €8,887 ± 12,059), and average daily cost per patient. Conclusion Hospitalized sHF patients have a worse initial prognosis, greater use of healthcare resources, and higher costs.
No takes yet. Share an insight, caveat, or question.
Bueno et al. (2022) conducted an observational in Heart Failure (n=3,083). Secondary heart failure diagnosis vs. Primary heart failure diagnosis was evaluated on 1-year mortality (in hospitalized patients) (p=<0.001). Hospitalized patients with a secondary diagnosis of heart failure had a higher 1-year mortality rate and higher healthcare costs compared to those with a primary heart failure diagnosis.
Synapse has enriched 10 related papers. Consider them for comparative context: